The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 02, 2020
Filed:
Feb. 26, 2016
Applicant:
University-industry Foundation, Yonsei University, Seoul, KR;
Inventors:
Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/36 (2006.01); A61K 31/5415 (2006.01); A61K 9/06 (2006.01); A61K 31/728 (2006.01); A61K 31/122 (2006.01); A61K 31/192 (2006.01); A61K 31/444 (2006.01); A61K 31/60 (2006.01); A61K 47/12 (2006.01); A61P 29/00 (2006.01); A61K 9/19 (2006.01); A61K 9/00 (2006.01); A61K 9/10 (2006.01); A61K 31/337 (2006.01); A61K 47/10 (2017.01); A61K 47/18 (2017.01); A61K 47/20 (2006.01); A61P 1/16 (2006.01); A61P 35/02 (2006.01); A61P 1/04 (2006.01);
U.S. Cl.
CPC ...
A61K 47/36 (2013.01); A61K 9/0019 (2013.01); A61K 9/06 (2013.01); A61K 9/10 (2013.01); A61K 9/19 (2013.01); A61K 31/122 (2013.01); A61K 31/192 (2013.01); A61K 31/337 (2013.01); A61K 31/444 (2013.01); A61K 31/5415 (2013.01); A61K 31/60 (2013.01); A61K 31/728 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/18 (2013.01); A61K 47/20 (2013.01); A61P 1/04 (2018.01); A61P 1/16 (2018.01); A61P 29/00 (2018.01); A61P 35/02 (2018.01);
Abstract
The present invention relates to a pharmaceutical composition containing a poorly soluble drug, hyaluronic acid, and a fatty acid, and to a method for preparing the same. The pharmaceutical composition of the present application has excellent stability even for long-term storage and allows a sustained release of the drug, thereby preventing an overdose of the drug and improving the therapeutic efficiency at an effected area.